Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionextracellular matrix structural constituent conferring tensile strength

COL4A3 COL4A4 COL6A1 COL6A2 COL11A2 COL27A1

1.36e-0846716GO:0030020
GeneOntologyMolecularFunctionextracellular matrix structural constituent

COL4A3 COL4A4 COL6A1 COL6A2 THBS3 COL11A2 COL27A1 LTBP2 LTBP4

2.16e-08188719GO:0005201
GeneOntologyMolecularFunctionglycosaminoglycan binding

THBS3 COL11A2 LTBP2 LGR6 LTBP4 NRP1 CEMIP

4.64e-05268717GO:0005539
GeneOntologyMolecularFunctionheparin binding

THBS3 COL11A2 LTBP2 LGR6 NRP1

6.08e-04192715GO:0008201
GeneOntologyMolecularFunctionclathrin heavy chain binding

LRP1 CEMIP

8.04e-0412712GO:0032050
GeneOntologyMolecularFunctionsulfur compound binding

THBS3 COL11A2 LRP1 LTBP2 LGR6 NRP1

1.01e-03323716GO:1901681
GeneOntologyMolecularFunctionRNA polymerase II cis-regulatory region sequence-specific DNA binding

TFEB ZBTB38 HOXC9 NFATC4 GLI1 ESRRA ZBTB22 PER1 SKOR1 ATF6B KLF2 TBX6

1.36e-0312447112GO:0000978
GeneOntologyMolecularFunctioncis-regulatory region sequence-specific DNA binding

TFEB ZBTB38 HOXC9 NFATC4 GLI1 ESRRA ZBTB22 PER1 SKOR1 ATF6B KLF2 TBX6

1.63e-0312717112GO:0000987
GeneOntologyMolecularFunctionRNA polymerase II transcription regulatory region sequence-specific DNA binding

TFEB ZBTB38 HOXC9 NFATC4 GLI1 ESRRA ZBTB22 PER1 SKOR1 ZNF619 ATF6B KLF2 TBX6

1.72e-0314597113GO:0000977
GeneOntologyMolecularFunctiontransmembrane receptor protein tyrosine kinase adaptor activity

IRS2 SH2B1

1.84e-0318712GO:0005068
GeneOntologyMolecularFunctiongrowth factor binding

COL6A1 LTBP2 LTBP4 NRP1

2.32e-03156714GO:0019838
GeneOntologyCellularComponentcollagen trimer

COL4A3 COL4A4 COL6A1 COL6A2 COL11A2 COL27A1

4.95e-0788706GO:0005581
GeneOntologyCellularComponentcomplex of collagen trimers

COL4A3 COL4A4 COL11A2 COL27A1

6.61e-0721704GO:0098644
GeneOntologyCellularComponentcollagen-containing extracellular matrix

COL4A3 COL4A4 COL6A1 COL6A2 THBS3 COL11A2 COL27A1 FIBCD1 LTBP2 LTBP4

1.02e-055307010GO:0062023
GeneOntologyCellularComponentextracellular matrix

COL4A3 COL4A4 COL6A1 COL6A2 THBS3 COL11A2 COL27A1 FIBCD1 LTBP2 LGR6 LTBP4

1.08e-056567011GO:0031012
GeneOntologyCellularComponentexternal encapsulating structure

COL4A3 COL4A4 COL6A1 COL6A2 THBS3 COL11A2 COL27A1 FIBCD1 LTBP2 LGR6 LTBP4

1.11e-056587011GO:0030312
GeneOntologyCellularComponentcollagen type IV trimer

COL4A3 COL4A4

1.64e-046702GO:0005587
GeneOntologyCellularComponentbasement membrane collagen trimer

COL4A3 COL4A4

3.06e-048702GO:0098651
GeneOntologyCellularComponentnetwork-forming collagen trimer

COL4A3 COL4A4

3.06e-048702GO:0098642
GeneOntologyCellularComponentcollagen network

COL4A3 COL4A4

3.06e-048702GO:0098645
GeneOntologyCellularComponentchromatin

TFEB COPS9 SFPQ HOXC9 L3MBTL1 NFATC4 ESRRA ZBTB22 CHD3 SGF29 ATF6B DNMT1 KLF2 TBX6

3.38e-0414807014GO:0000785
GeneOntologyCellularComponentfibrillar collagen trimer

COL11A2 COL27A1

7.14e-0412702GO:0005583
GeneOntologyCellularComponentbanded collagen fibril

COL11A2 COL27A1

7.14e-0412702GO:0098643
GeneOntologyCellularComponentendoplasmic reticulum lumen

COL4A3 COL4A4 COL6A1 COL6A2 COL11A2 COL27A1

8.56e-04332706GO:0005788
GeneOntologyCellularComponentclathrin-coated pit

REPS1 LRP1 CEMIP

2.46e-0380703GO:0005905
HumanPhenoGlomerular basement membrane lamellation

COL4A3 COL4A4

5.33e-053222HP:0030034
HumanPhenoThin glomerular basement membrane

COL4A3 COL4A4

5.33e-053222HP:0012577
HumanPhenoAbnormality of lens shape

COL4A3 COL4A4 LTBP2

5.47e-0518223HP:0011526
HumanPhenoReduced maximal expiratory pressure

COL6A1 COL6A2

1.06e-044222HP:0012497
HumanPhenoReduced muscle collagen VI

COL6A1 COL6A2

1.06e-044222HP:0030095
HumanPhenoCurved toe phalanx

COL6A1 COL6A2

1.06e-044222HP:0010176
HumanPhenoIncreased laxity of fingers

COL6A1 COL6A2

1.77e-045222HP:0006149
MousePhenosensorineural hearing loss

COL4A3 COL4A4 CACNA1D COL11A2

1.48e-0537574MP:0004740
MousePhenosensorineural hearing impairment

COL4A3 COL4A4 CACNA1D COL11A2

1.65e-0538574MP:0006329
DomainCollagen

COL4A3 COL4A4 COL6A1 COL6A2 COL11A2 COL27A1

8.40e-0785716IPR008160
DomainCollagen

COL4A3 COL4A4 COL6A1 COL6A2 COL11A2 COL27A1

8.40e-0785716PF01391
DomainTSPN

THBS3 COL11A2 COL27A1

8.83e-0523713SM00210
DomainC4

COL4A3 COL4A4

2.12e-046712SM00111
Domain-

COL4A3 COL4A4

2.12e-0467122.170.240.10
DomainCollagen_VI_NC

COL4A3 COL4A4

2.12e-046712IPR001442
DomainC4

COL4A3 COL4A4

2.12e-046712PF01413
DomainNC1_IV

COL4A3 COL4A4

2.12e-046712PS51403
DomainTB

LTBP2 LTBP4

2.96e-047712PF00683
DomainEGF_CA

THBS3 LRP1 LTBP2 LTBP4

3.22e-0486714PF07645
Domain-

LTBP2 LTBP4

3.93e-0487123.90.290.10
DomainTB

LTBP2 LTBP4

5.04e-049712PS51364
DomainTB_dom

LTBP2 LTBP4

5.04e-049712IPR017878
DomainEGF_Ca-bd_CS

THBS3 LRP1 LTBP2 LTBP4

5.09e-0497714IPR018097
DomainEGF_CA

THBS3 LRP1 LTBP2 LTBP4

5.50e-0499714PS01187
DomainFib_collagen_C

COL11A2 COL27A1

7.66e-0411712IPR000885
DomainCOLFI

COL11A2 COL27A1

7.66e-0411712PF01410
DomainNC1_FIB

COL11A2 COL27A1

7.66e-0411712PS51461
DomainFib_collagen_C

COL11A2 COL27A1

7.66e-0411712PD002078
DomainCOLFI

COL11A2 COL27A1

7.66e-0411712SM00038
DomainEGF_CA

THBS3 LRP1 LTBP2 LTBP4

1.20e-03122714SM00179
DomainEGF-like_Ca-bd_dom

THBS3 LRP1 LTBP2 LTBP4

1.28e-03124714IPR001881
DomainLaminin_G

THBS3 COL11A2 COL27A1

1.40e-0358713IPR001791
DomainGrowth_fac_rcpt_

THBS3 LRP1 LTBP2 LTBP4

2.95e-03156714IPR009030
PathwayREACTOME_COLLAGEN_CHAIN_TRIMERIZATION

COL4A3 COL4A4 COL6A1 COL6A2 COL11A2 COL27A1

8.21e-0944496M27812
PathwayREACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES

COL4A3 COL4A4 COL6A1 COL6A2 COL11A2 COL27A1

6.17e-0861496M27103
PathwayREACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES

COL4A3 COL4A4 COL6A1 COL6A2 COL11A2 COL27A1

1.09e-0767496M26999
PathwayREACTOME_COLLAGEN_CHAIN_TRIMERIZATION

COL4A3 COL4A4 COL6A1 COL6A2 COL11A2

2.81e-0741495MM15538
PathwayREACTOME_NCAM1_INTERACTIONS

COL4A3 COL4A4 CACNA1D COL6A1 COL6A2

3.18e-0742495M7169
PathwayPID_SYNDECAN_1_PATHWAY

COL4A3 COL4A4 COL6A1 COL6A2 COL11A2

5.07e-0746495M198
PathwayREACTOME_NCAM1_INTERACTIONS

COL4A3 COL4A4 COL6A1 COL6A2

5.99e-0720494MM15061
PathwayREACTOME_COLLAGEN_FORMATION

COL4A3 COL4A4 COL6A1 COL6A2 COL11A2 COL27A1

6.42e-0790496M631
PathwayREACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES

COL4A3 COL4A4 COL6A1 COL6A2 COL11A2

7.75e-0750495MM14796
PathwayREACTOME_COLLAGEN_DEGRADATION

COL4A3 COL4A4 COL6A1 COL6A2 COL11A2

1.04e-0653495MM14566
PathwayREACTOME_SIGNALING_BY_PDGF

COL4A3 COL4A4 COL6A1 COL6A2 THBS3

1.50e-0657495MM14713
PathwayREACTOME_SIGNALING_BY_PDGF

COL4A3 COL4A4 COL6A1 COL6A2 THBS3

1.64e-0658495M2049
PathwayREACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES

COL4A3 COL4A4 COL6A1 COL6A2 COL11A2

2.11e-0661495MM14637
PathwayREACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH

COL4A3 COL4A4 CACNA1D COL6A1 COL6A2

2.49e-0663495M11187
PathwayREACTOME_COLLAGEN_DEGRADATION

COL4A3 COL4A4 COL6A1 COL6A2 COL11A2

2.69e-0664495M26953
PathwayPID_INTEGRIN1_PATHWAY

COL4A3 COL4A4 COL6A1 COL6A2 COL11A2

3.14e-0666495M18
PathwayPID_AVB3_INTEGRIN_PATHWAY

COL4A3 COL4A4 COL6A1 COL6A2 COL11A2

5.54e-0674495M160
PathwayREACTOME_COLLAGEN_FORMATION

COL4A3 COL4A4 COL6A1 COL6A2 COL11A2

6.32e-0676495MM14573
PathwayREACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION

COL4A3 COL4A4 COL6A1 COL6A2 COL11A2 COL27A1 LTBP2 LTBP4

8.10e-06300498M610
PathwayREACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH

COL4A3 COL4A4 COL6A1 COL6A2

8.72e-0638494MM14969
PathwayKEGG_ECM_RECEPTOR_INTERACTION

COL4A4 COL6A1 COL6A2 THBS3 COL11A2

1.03e-0584495M7098
PathwayREACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES

COL4A3 COL4A4 COL6A1 COL6A2 THBS3 COL11A2 COL27A1 IRS2 DNMT1 NRP1

1.17e-055324910M27870
PathwayREACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION

COL4A3 COL4A4 COL6A1 COL6A2 COL11A2 LTBP2 LTBP4

2.83e-05258497MM14572
PathwayREACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX

COL4A3 COL4A4 COL6A1 COL6A2 COL11A2

4.55e-05114495MM14571
PathwayREACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES

COL4A3 COL4A4 COL6A1 COL6A2 THBS3 COL11A2 IRS2 NRP1

8.67e-05418498MM15587
PathwayREACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX

COL4A3 COL4A4 COL6A1 COL6A2 COL11A2

1.21e-04140495M587
PathwayREACTOME_ECM_PROTEOGLYCANS

COL4A3 COL4A4 COL6A1 COL6A2

1.38e-0476494M27219
PathwayREACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS

COL4A3 COL4A4 COL6A1 COL6A2

1.38e-0476494MM14867
PathwayREACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS

COL4A3 COL4A4 COL11A2

1.82e-0432493MM14924
PathwayREACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS

COL4A3 COL4A4 COL6A1 COL6A2

2.12e-0485494M16441
PathwayREACTOME_NERVOUS_SYSTEM_DEVELOPMENT

COL4A3 COL4A4 COL6A1 COL6A2 IRS2 NRP1

2.73e-04261496MM15676
PathwayBIOCARTA_NPP1_PATHWAY

COL4A3 COL4A4

5.23e-0410492M22040
PathwayBIOCARTA_NPP1_PATHWAY

COL4A3 COL4A4

5.23e-0410492MM1560
PathwayWP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING

COL4A4 COL6A2 THBS3 COL11A2 IRS2 ATF6B

5.93e-04302496M39719
PathwayKEGG_FOCAL_ADHESION

COL4A4 COL6A1 COL6A2 THBS3 COL11A2

6.14e-04199495M7253
PathwayBIOCARTA_VITCB_PATHWAY

COL4A3 COL4A4

6.38e-0411492M15422
PathwayREACTOME_SIGNALING_BY_LEPTIN

IRS2 SH2B1

6.38e-0411492M27195
PathwayBIOCARTA_VITCB_PATHWAY

COL4A3 COL4A4

7.64e-0412492MM1526
PathwayWP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY

COL4A4 COL6A2 THBS3 COL11A2 IRS2 ATF6B

8.84e-04326496MM15917
PathwayBIOCARTA_ACE2_PATHWAY

COL4A3 COL4A4

9.01e-0413492MM1347
PathwayBIOCARTA_ACE2_PATHWAY

COL4A3 COL4A4

9.01e-0413492M12950
PathwayBIOCARTA_PLATELETAPP_PATHWAY

COL4A3 COL4A4

1.05e-0314492MM1458
PathwayBIOCARTA_PLATELETAPP_PATHWAY

COL4A3 COL4A4

1.05e-0314492M6487
PathwayWP_PI3KAKT_SIGNALING

COL4A3 COL4A4 COL6A1 COL6A2 THBS3 ATF6B

1.08e-03339496M39736
PathwayREACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS

COL4A3 COL4A4 COL11A2

1.12e-0359493M27218
PathwayREACTOME_LAMININ_INTERACTIONS

COL4A3 COL4A4

1.21e-0315492MM14922
PathwayREACTOME_ANCHORING_FIBRIL_FORMATION

COL4A3 COL4A4

1.21e-0315492M27161
PathwayREACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS

COL4A3 COL4A4

1.75e-0318492M27164
PathwayREACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS

COL4A3 COL4A4

1.75e-0318492MM14882
PathwayBIOCARTA_AMI_PATHWAY

COL4A3 COL4A4

2.16e-0320492M15394
PathwayBIOCARTA_INTRINSIC_PATHWAY

COL4A3 COL4A4

2.86e-0323492M15997
PathwayBIOCARTA_INTRINSIC_PATHWAY

COL4A3 COL4A4

2.86e-0323492MM1427
PathwayKEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY

CACNA1D ATF6B

3.11e-0324492M47509
PathwayREACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING

IRS2 SH2B1

3.11e-0324492M519
PathwayKEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY

CACNA1D ATF6B

3.37e-0325492M47510
PathwayKEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY

CACNA1D ATF6B

3.37e-0325492M47511
PathwayREACTOME_NERVOUS_SYSTEM_DEVELOPMENT

COL4A3 COL4A4 CACNA1D COL6A1 COL6A2 IRS2 NRP1

3.51e-03575497M29853
PathwayREACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION

RRAGD CHD3

3.93e-0327492MM15537
PathwayWP_FOCAL_ADHESION

COL4A4 COL6A2 THBS3 COL11A2

3.99e-03187494MM15913
PathwayREACTOME_MET_ACTIVATES_PTK2_SIGNALING

COL11A2 COL27A1

4.84e-0330492M27772
PathwayREACTOME_LAMININ_INTERACTIONS

COL4A3 COL4A4

4.84e-0330492M27216
Pubmed

Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.

COL4A3 COL4A4 COL6A1 COL6A2 COL11A2 COL27A1 LTBP2 LTBP4

2.84e-0917571828071719
Pubmed

The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.

COL4A4 COL6A1 COL6A2 COL27A1 LTBP2 LTBP4

1.24e-0616771622159717
Pubmed

Impact of cytosine methylation on DNA binding specificities of human transcription factors.

TFEB HOXC9 NFATC4 ESRRA ZBTB22 SKOR1 ATF6B KLF2 TBX6

1.65e-0654471928473536
Pubmed

Latent TGF-β binding protein 2 and 4 have essential overlapping functions in microfibril development.

LTBP2 LTBP4

4.11e-06271228252045
Pubmed

Mutation analysis of COL4A3 and COL4A4 genes in a Chinese autosomal-dominant Alport syndrome family.

COL4A3 COL4A4

4.11e-06271228674241
Pubmed

Lipopolysaccharide Downregulates Kruppel-Like Factor 2 (KLF2) via Inducing DNMT1-Mediated Hypermethylation in Endothelial Cells.

DNMT1 KLF2

4.11e-06271228578476
Pubmed

Two genes, COL4A3 and COL4A4 coding for the human alpha3(IV) and alpha4(IV) collagen chains are arranged head-to-head on chromosome 2q36.

COL4A3 COL4A4

4.11e-0627129537506
Pubmed

Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome.

COL4A3 COL4A4

4.11e-0627127987396
Pubmed

Heterozygous COL4A3/COL4A4 mutations: the hidden part of the iceberg?

COL4A3 COL4A4

4.11e-06271235090027
Pubmed

The COL4A3 and COL4A4 Digenic Mutations in cis Result in Benign Familial Hematuria in a Large Chinese Family.

COL4A3 COL4A4

4.11e-06271229742505
Pubmed

Further characterization of the three polypeptide chains of bovine and human short-chain collagen (intima collagen).

COL6A1 COL6A2

4.11e-0627126852033
Pubmed

Is there a dominant-negative effect in individuals with heterozygous disease-causing variants in COL4A3/COL4A4?

COL4A3 COL4A4

4.11e-06271238214412
Pubmed

Novel mutations in collagen VI genes: expansion of the Bethlem myopathy phenotype.

COL6A1 COL6A2

4.11e-06271211865138
Pubmed

Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases.

COL4A3 COL4A4

4.11e-06271217216251
Pubmed

Heterozygous Urinary Abnormality-Causing Variants of COL4A3 and COL4A4 Affect Severity of Autosomal Recessive Alport Syndrome.

COL4A3 COL4A4

4.11e-06271235369551
Pubmed

The exon organization of the triple-helical coding regions of the human alpha 1(VI) and alpha 2(VI) collagen genes is highly similar.

COL6A1 COL6A2

4.11e-0627121765372
Pubmed

Collagen type IV-related nephropathies in Portugal: pathogenic COL4A3 and COL4A4 mutations and clinical characterization of 25 families.

COL4A3 COL4A4

4.11e-06271225307543
Pubmed

Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.

COL4A3 COL4A4

4.11e-06271227281700
Pubmed

[From Alport syndrome to benign familial hematuria: clinical and genetic aspect].

COL4A3 COL4A4

4.11e-06271216895672
Pubmed

COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome.

COL4A3 COL4A4

4.11e-06271224052634
Pubmed

Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis.

COL4A3 COL4A4

4.11e-06271219357112
Pubmed

Type-IV collagen related diseases.

COL4A3 COL4A4

4.11e-06271212768082
Pubmed

Collagen type VI‑α1 and 2 repress the proliferation, migration and invasion of bladder cancer cells.

COL6A1 COL6A2

4.11e-06271233982770
Pubmed

Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis.

COL4A3 COL4A4

4.11e-06271225229338
Pubmed

COL4A3/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy.

COL4A3 COL4A4

4.11e-06271217942953
Pubmed

Polymorphisms in COL4A3 and COL4A4 genes associated with keratoconus.

COL4A3 COL4A4

4.11e-06271220029656
Pubmed

Persistent familial hematuria in children and the locus for thin basement membrane nephropathy.

COL4A3 COL4A4

4.11e-06271216235097
Pubmed

Whole exome sequencing reveals novel COL4A3 and COL4A4 mutations and resolves diagnosis in Chinese families with kidney disease.

COL4A3 COL4A4

4.11e-06271225381091
Pubmed

Collagen type IV (alpha3-alpha4) nephropathy: from isolated haematuria to renal failure.

COL4A3 COL4A4

4.11e-06271215280517
Pubmed

Inhibition of DNMT1 and ERRα crosstalk suppresses breast cancer via derepression of IRF4.

ESRRA DNMT1

4.11e-06271232855526
Pubmed

Ullrich disease due to deficiency of collagen VI in the sarcolemma.

COL6A1 COL6A2

4.11e-06271214981181
Pubmed

The genetics of thin basement membrane nephropathy.

COL4A3 COL4A4

4.11e-06271215880327
Pubmed

Collagen type VI and related disorders: Bethlem myopathy and Ullrich scleroatonic muscular dystrophy.

COL6A1 COL6A2

4.11e-06271212374585
Pubmed

Presumed COL4A3/COL4A4 Missense/Synonymous Variants Induce Aberrant Splicing.

COL4A3 COL4A4

4.11e-06271235386907
Pubmed

COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome.

COL4A3 COL4A4

4.11e-06271212028435
Pubmed

Polymorphism analysis of COL4A3 and COL4A4 genes in Greek patients with keratoconus.

COL4A3 COL4A4

4.11e-06271225083577
Pubmed

Identification of the NC1 domain of {alpha}3 chain as critical for {alpha}3{alpha}4{alpha}5 type IV collagen network assembly.

COL4A3 COL4A4

4.11e-06271220847057
Pubmed

Sequence analysis of alpha 1(VI) and alpha 2(VI) chains of human type VI collagen reveals internal triplication of globular domains similar to the A domains of von Willebrand factor and two alpha 2(VI) chain variants that differ in the carboxy terminus.

COL6A1 COL6A2

4.11e-0627122551668
Pubmed

COL4A3/COL4A4 mutations link familial hematuria and focal segmental glomerulosclerosis. glomerular epithelium destruction via basement membrane thinning?

COL4A3 COL4A4

4.11e-06271218661361
Pubmed

How to resolve confusion in the clinical setting for the diagnosis of heterozygous COL4A3 or COL4A4 gene variants? Discussion and suggestions from nephrologists.

COL4A3 COL4A4

4.11e-06271232232700
Pubmed

Identification and characterization of novel collagen VI non-canonical splicing mutations causing Ullrich congenital muscular dystrophy.

COL6A1 COL6A2

4.11e-06271219309692
Pubmed

A genetic linkage map of mouse chromosome 10: localization of eighteen molecular markers using a single interspecific backcross.

COL6A1 COL6A2 GLI1

5.43e-06177131975791
Pubmed

Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation.

COL4A3 COL4A4 DNMT1

6.51e-06187139160753
Pubmed

Proteomic characterization of human multiple myeloma bone marrow extracellular matrix.

COL4A3 COL6A2 COL11A2 COL27A1

8.13e-066271428344315
Pubmed

Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.

COL4A3 COL6A1 COL6A2 COL11A2 LTBP4

8.67e-0613571528675934
Pubmed

Mosaicism for dominant collagen 6 mutations as a cause for intrafamilial phenotypic variability.

COL6A1 COL6A2

1.23e-05371225204870
Pubmed

Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome.

COL4A3 COL4A4

1.23e-05371227576055
Pubmed

Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome.

COL4A3 COL4A4

1.23e-05371215954103
Pubmed

RagD auto-activating mutations impair MiT/TFE activity in kidney tubulopathy and cardiomyopathy syndrome.

TFEB RRAGD

1.23e-05371237188688
Pubmed

Alport syndrome: impact of digenic inheritance in patients management.

COL4A3 COL4A4

1.23e-05371227859054
Pubmed

Sixteen novel mutations identified in COL4A3, COL4A4, and COL4A5 genes in Slovenian families with Alport syndrome and benign familial hematuria.

COL4A3 COL4A4

1.23e-05371217396119
Pubmed

A mouse Col4a4 mutation causing Alport glomerulosclerosis with abnormal collagen α3α4α5(IV) trimers.

COL4A3 COL4A4

1.23e-05371224522496
Pubmed

Collagen types in various layers of the human aorta and their changes with the atherosclerotic process.

COL4A3 COL4A4

1.23e-0537123089234
Pubmed

Collagen VI protects against neuronal apoptosis elicited by ultraviolet irradiation via an Akt/phosphatidylinositol 3-kinase signaling pathway.

COL6A1 COL6A2

1.23e-05371221459131
Pubmed

Extracellular Matrix Disorganization and Sarcolemmal Alterations in COL6-Related Myopathy Patients with New Variants of COL6 Genes.

COL6A1 COL6A2

1.23e-05371236982625
Pubmed

SH2B1 enhances insulin sensitivity by both stimulating the insulin receptor and inhibiting tyrosine dephosphorylation of insulin receptor substrate proteins.

IRS2 SH2B1

1.23e-05371219542202
Pubmed

Amino acid sequence of the triple-helical domain of human collagen type VI.

COL6A1 COL6A2

1.23e-0537123198591
Pubmed

Collagen IV alpha 3, alpha 4, and alpha 5 chains in rodent basal laminae: sequence, distribution, association with laminins, and developmental switches.

COL4A3 COL4A4

1.23e-0537127962065
Pubmed

Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome.

COL4A3 COL4A4

1.23e-05371228542346
Pubmed

New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype.

COL6A1 COL6A2

1.23e-05371212840783
Pubmed

Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.

COL4A3 COL4A4

1.23e-05371228704582
Pubmed

Cloning and sequence analysis of cDNAs encoding the alpha 1, alpha 2 and alpha 3 chains of mouse collagen VI.

COL6A1 COL6A2

1.23e-0537128489506
Pubmed

Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance.

COL6A1 COL6A2

1.23e-05371218366090
Pubmed

Identification of noncollagenous sites encoding specific interactions and quaternary assembly of alpha 3 alpha 4 alpha 5(IV) collagen: implications for Alport gene therapy.

COL4A3 COL4A4

1.23e-05371218930919
Pubmed

Integration of Genetic Testing and Pathology for the Diagnosis of Adults with FSGS.

COL4A3 COL4A4

1.23e-05371230647093
Pubmed

Four novel mutations identified in the COL4A3, COL4A4 and COL4A5 genes in 10 families with Alport syndrome.

COL4A3 COL4A4

1.23e-05371238978054
Pubmed

Spatial and temporal changes of type VI collagen expression during mouse development.

COL6A1 COL6A2

1.23e-0537128853993
Pubmed

Novel collagen VI mutations identified in Chinese patients with Ullrich congenital muscular dystrophy.

COL6A1 COL6A2

1.23e-05371224801232
Pubmed

Next-generation sequencing in patients with familial FSGS: first report of collagen gene mutations in Tunisian patients.

COL4A3 COL4A4

1.23e-05371233654185
Pubmed

Alport Syndrome

COL4A3 COL4A4

1.23e-05371220301386
Pubmed

Collagen VI related muscle disorders.

COL6A1 COL6A2

1.23e-05371216141002
Pubmed

Quantitative evaluation of collagen type VI and SOD gene expression in the nuchal skin of human fetuses with trisomy 21.

COL6A1 COL6A2

1.23e-05371217602442
Pubmed

Genetic Variants of the COL4A3 , COL4A4 , and COL4A5 Genes Contribute to Thinned Glomerular Basement Membrane Lesions in Sporadic IgA Nephropathy Patients.

COL4A3 COL4A4

1.23e-05371236130833
Pubmed

A human-mouse chimera of the alpha3alpha4alpha5(IV) collagen protomer rescues the renal phenotype in Col4a3-/- Alport mice.

COL4A3 COL4A4

1.23e-05371214507670
Pubmed

Genetic diagnosis of Alport syndrome in 16 Chinese families.

COL4A3 COL4A4

1.23e-05371238433557
Pubmed

Recombinant expression and structural and binding properties of alpha 1(VI) and alpha 2(VI) chains of human collagen type VI.

COL6A1 COL6A2

1.23e-0537128168508
Pubmed

Transcriptional activation of RagD GTPase controls mTORC1 and promotes cancer growth.

TFEB RRAGD

1.23e-05371228619945
Pubmed

Expression of collagen alpha 1(VI), alpha 2(VI), and alpha 3(VI) chains in the pregnant mouse uterus.

COL6A1 COL6A2

1.23e-0537127780011
Pubmed

Evidence of digenic inheritance in Alport syndrome.

COL4A3 COL4A4

1.23e-05371225575550
Pubmed

Collagen VI-Related Dystrophies

COL6A1 COL6A2

1.23e-05371220301676
Pubmed

Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures.

COL6A1 COL6A2

1.23e-0537128782832
Pubmed

Collagen VI involvement in Ullrich syndrome: a clinical, genetic, and immunohistochemical study.

COL6A1 COL6A2

1.23e-05371212011280
Pubmed

Characterization of three constituent chains of collagen type VI by peptide sequences and cDNA clones.

COL6A1 COL6A2

1.23e-0537123665927
Pubmed

Collagen type VI myopathies.

COL6A1 COL6A2

1.23e-05371224443028
Pubmed

Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy.

COL6A1 COL6A2

1.23e-05371215563506
Pubmed

Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases.

COL4A3 COL4A4

1.23e-05371224033287
Pubmed

Expression of type VI collagen in the developing mouse heart.

COL6A1 COL6A2

1.23e-0537129520112
Pubmed

Characterization of assembly of recombinant type IV collagen alpha3, alpha4, and alpha5 chains in transfected cell strains.

COL4A3 COL4A4

1.23e-05371214633121
Pubmed

Tendon Extracellular Matrix Remodeling and Defective Cell Polarization in the Presence of Collagen VI Mutations.

COL6A1 COL6A2

1.23e-05371232053901
Pubmed

[Molecular mechanism of SH2B1 in regulating JAK2/IRS2 during obesity development].

IRS2 SH2B1

1.23e-05371220360640
Pubmed

Cloning and chromosomal localization of human genes encoding the three chains of type VI collagen.

COL6A1 COL6A2

1.23e-0537123348212
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

TFEB PRR12 REPS1 GLI1 KBTBD11 STRN4 PER1 PDZD8 SNX15 IRS2 LTBP4

1.42e-051105711135748872
Pubmed

A census of human transcription factors: function, expression and evolution.

TFEB ZBTB38 HOXC9 NFATC4 GLI1 ESRRA SKOR1 ATF6B KLF2 TBX6

1.53e-05908711019274049
Pubmed

Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.

COL4A3 COL4A4 COL6A1 COL6A2 LTBP4

1.59e-0515371525037231
Pubmed

Foxc2 is essential for podocyte function.

COL4A3 COL4A4 NRP1

1.60e-052471331062503
Pubmed

Protein interactome reveals converging molecular pathways among autism disorders.

SFPQ L3MBTL1 EFS GPATCH1 VPS51 LTBP4 DNMT1 BEGAIN

1.88e-0556071821653829
Pubmed

Nature and the multiple functions of the 67-kD elastin-/laminin binding protein.

COL4A3 COL4A4

2.46e-0547127827955
Pubmed

4E-BP2/SH2B1/IRS2 Are Part of a Novel Feedback Loop That Controls β-Cell Mass.

IRS2 SH2B1

2.46e-05471227217487
Pubmed

Latent transforming growth factor-beta (TGF-beta) binding proteins: orchestrators of TGF-beta availability.

LTBP2 LTBP4

2.46e-05471215611103
Pubmed

Deposition of collagen VI in the extracellular matrix during mouse embryogenesis correlates with expression of the alpha 3(VI) subunit gene.

COL6A1 COL6A2

2.46e-0547128806434
GeneFamilyCollagens

COL4A3 COL4A4 COL6A1 COL6A2 COL11A2 COL27A1

4.06e-0946536490
GeneFamilyLatent transforming growth factor beta binding proteins

LTBP2 LTBP4

5.04e-054532628
CoexpressionNABA_COLLAGENS

COL4A3 COL4A4 COL6A1 COL6A2 COL11A2 COL27A1

1.79e-0943716MM17060
CoexpressionNABA_COLLAGENS

COL4A3 COL4A4 COL6A1 COL6A2 COL11A2 COL27A1

2.07e-0944716M3005
CoexpressionNABA_CORE_MATRISOME

COL4A3 COL4A4 COL6A1 COL6A2 THBS3 COL11A2 COL27A1 LTBP2 LTBP4

4.87e-08270719MM17057
CoexpressionNABA_CORE_MATRISOME

COL4A3 COL4A4 COL6A1 COL6A2 THBS3 COL11A2 COL27A1 LTBP2 LTBP4

5.70e-08275719M5884
CoexpressionNABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS

COL6A1 COL6A2 COL11A2 LTBP2

1.12e-0629714MM17055
CoexpressionNABA_BASEMENT_MEMBRANES

COL4A3 COL4A4 COL6A1 COL6A2

4.20e-0640714M5887
CoexpressionLEE_BMP2_TARGETS_UP

COL4A4 COL6A1 COL6A2 SYNPO2 THBS3 WIPI1 RRAGD EFS LRP1 CHD3 LTBP4

7.61e-067807111M2324
CoexpressionGAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS

COL6A1 COL6A2 SYNPO2 NFATC4 COL27A1 SNX18 LRP1 LTBP2 NRP1

8.79e-06505719M39167
CoexpressionBROWNE_HCMV_INFECTION_18HR_DN

COL6A1 COL6A2 THBS3 SFPQ L3MBTL1 CEMIP

1.02e-05182716M6641
CoexpressionLEE_BMP2_TARGETS_UP

COL4A4 COL6A1 COL6A2 SYNPO2 THBS3 WIPI1 RRAGD EFS LRP1 CHD3 LTBP4

1.02e-058057111MM1067
CoexpressionWEST_ADRENOCORTICAL_TUMOR_DN

COL4A3 COL4A4 COL6A1 FKBP9 LRP1 CHD3 VPS51 LTBP4 KLF2

1.63e-05546719M3837
CoexpressionJACKSON_DNMT1_TARGETS_DN

COL6A1 COL6A2 DNMT1

2.45e-0521713MM1196
CoexpressionJACKSON_DNMT1_TARGETS_DN

COL6A1 COL6A2 DNMT1

2.83e-0522713M1627
CoexpressionBOQUEST_STEM_CELL_UP

COL6A1 COL6A2 EFS LRP1 IRS2 LTBP2

7.67e-05261716M1834
CoexpressionERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_DN

RRAGD PDZD8 IRS2

8.93e-0532713M40951
CoexpressionMURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL

COL6A1 COL6A2 ZBTB38 WIPI1 FKBP9 C3orf80 LTBP2 NRP1 CEMIP

9.06e-05681719M39175
CoexpressionREN_ALVEOLAR_RHABDOMYOSARCOMA_DN

COL6A1 COL6A2 WIPI1 LRP1 NRP1 KLF2 CEMIP

1.17e-04407717M19541
CoexpressionCLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN

COL6A1 COL6A2 LTBP2

1.17e-0435713M11788
CoexpressionLIM_MAMMARY_LUMINAL_MATURE_DN

COL6A1 COL6A2 IRS2 LTBP4

1.25e-0494714M2580
CoexpressionCLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN

COL6A1 COL6A2 LTBP2

1.28e-0436713MM1212
CoexpressionLIM_MAMMARY_LUMINAL_MATURE_DN

COL6A1 COL6A2 IRS2 LTBP4

1.31e-0495714MM1328
CoexpressionGAVIN_FOXP3_TARGETS_CLUSTER_T4

RRAGD SNX18 C3orf80 NRP1

1.42e-0497714M1729
CoexpressionTRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL

COL6A1 COL6A2 LRP1 LTBP4 NRP1 KLF2

1.53e-04296716M41675
CoexpressionGAVIN_FOXP3_TARGETS_CLUSTER_T4

RRAGD SNX18 C3orf80 NRP1

1.59e-04100714MM1215
CoexpressionMIKKELSEN_MCV6_HCP_WITH_H3K27ME3

CACNA1D CNNM1 HOXC9 FIBCD1 SKOR1 FAM83G SHE

1.84e-04438717M1954
CoexpressionAIZARANI_LIVER_C21_STELLATE_CELLS_1

COL6A1 COL6A2 SYNPO2 LRP1 LTBP4

1.85e-04194715M39122
CoexpressionMIKKELSEN_MCV6_HCP_WITH_H3K27ME3

CACNA1D CNNM1 HOXC9 FIBCD1 SKOR1 FAM83G SHE

1.89e-04440717MM832
CoexpressionGSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP

NSFL1C SNX18 FKBP9 PDZD8 IRS2

2.03e-04198715M7948
CoexpressionGSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_DN

SHE TEX13B VPS51 NRP1 KLF2

2.03e-04198715M5701
CoexpressionGSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN

OTUD5 STRN4 SNX15 SH2B1 TBX6

2.08e-04199715M6211
CoexpressionGSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP

WIPI1 NOA1 SCAI DNMT1 NRP1

2.13e-04200715M7795
CoexpressionGSE28237_EARLY_VS_LATE_GC_BCELL_DN

PRR12 REPS1 NSFL1C OTUD5 SNX15

2.13e-04200715M4894
CoexpressionGSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_DN

COL6A1 COL11A2 FKBP9 LRP1 NRP1

2.13e-04200715M8217
CoexpressionGSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_UP

TFEB COL11A2 GLI1 NRP1 TBX6

2.13e-04200715M8209
CoexpressionGSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_DN

ESRRA PER1 LRP1 LTBP2 SH2B1

2.13e-04200715M9067
CoexpressionGSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_UP

LRP1 LTBP2 STAC DNMT1 NRP1

2.13e-04200715M9922
CoexpressionGSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN

COL6A1 RRAGD EFS LRP1 LTBP2

2.13e-04200715M6193
CoexpressionGSE17721_PAM3CSK4_VS_CPG_1H_BMDC_UP

RRAGD EFS GLI1 LRP1 IGDCC3

2.13e-04200715M3852
CoexpressionHAY_BONE_MARROW_STROMAL

COL6A1 COL6A2 SYNPO2 HOXC9 EFS NFATC4 FKBP9 LTBP2 NRP1

2.21e-04767719M39209
CoexpressionTABULA_MURIS_SENIS_BRAIN_NON_MYELOID_NEURON_AGEING

SYNPO2 WIPI1 GPATCH1 ZBTB22 PER1 LRP1 PCSK1N CHD3 ARHGAP27 BEGAIN

2.40e-049547110MM3689
CoexpressionHE_LIM_SUN_FETAL_LUNG_C0_LATE_AIRWAY_SMC_CELL

SYNPO2 LTBP2 LGR6 KLF2

2.72e-04115714M45671
CoexpressionMCDOWELL_ACUTE_LUNG_INJURY_DN

THBS3 LTBP4 NRP1

2.84e-0447713M1650
CoexpressionCUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL

COL6A1 COL6A2 LRP1 LTBP4

2.91e-04117714M39300
CoexpressionZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL

COL6A1 COL6A2 WIPI1 FKBP9 LRP1 LTBP4

3.06e-04337716MM16606
CoexpressionMATZUK_PREOVULATORY_FOLLICLE

IRS2 SH2B1

3.21e-0410712M1827
CoexpressionBROWNE_HCMV_INFECTION_48HR_DN

COL6A1 COL6A2 THBS3 WIPI1 NFATC4 FKBP9 LTBP2

3.28e-04482717M12144
CoexpressionMCDOWELL_ACUTE_LUNG_INJURY_DN

THBS3 LTBP4 NRP1

3.83e-0452713MM693
CoexpressionZHANG_UTERUS_C2_SECRETORY_STROMAL3_RAMP3_HIGH_CELL

COL6A1 COL6A2 WIPI1 LRP1 LTBP4

3.97e-04229715MM16607
CoexpressionKIM_GERMINAL_CENTER_T_HELPER_DN

PER1 IRS2

4.69e-0412712M1408
CoexpressionDESCARTES_FETAL_THYMUS_STROMAL_CELLS

COL6A1 FKBP9 LRP1 LTBP4

5.29e-04137714M40313
CoexpressionGAO_LARGE_INTESTINE_ADULT_CE_OLFM4HIGH_STEM_CELL

PRR12 CNNM1 NFATC4 ANKMY1 CEP152 BEGAIN

5.39e-04375716M39162
CoexpressionSCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_DN

COL6A2 LRP1 PCSK1N ARHGAP27 VPS51

5.40e-04245715M41070
CoexpressionDAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP

COL11A2 RRAGD

5.53e-0413712M13055
CoexpressionONDER_CDH1_TARGETS_1_UP

WIPI1 EFS PER1 CEP152

5.59e-04139714M18757
CoexpressionPOMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN

NFATC4 GLI1 LTBP2

6.12e-0461713M8510
CoexpressionHU_FETAL_RETINA_FIBROBLAST

COL6A2 SYNPO2 COL27A1 FKBP9 LTBP4 KLF2

6.19e-04385716M39264
CoexpressionAtlasDevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_200

COL4A4 COL6A1 COL6A2 LTBP4

1.79e-0627704gudmap_developingGonad_e18.5_epididymis_200_k4
CoexpressionAtlasDevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#1_top-relative-expression-ranked_500

COL4A4 COL6A1 COL6A2 THBS3 LTBP4

3.70e-0671705gudmap_developingGonad_P2_epididymis_500_k1
CoexpressionAtlasDevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#5_top-relative-expression-ranked_1000

COL4A3 COL4A4 COL6A1 COL6A2 THBS3 LTBP4

7.12e-06141706gudmap_developingGonad_P2_epididymis_1000_k5
CoexpressionAtlasStromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4

COL6A1 COL6A2 SYNPO2 WIPI1 FKBP9 LRP1 LTBP2 LTBP4 NRP1

1.80e-05455709GSM777055_500
CoexpressionAtlasDevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500

COL4A4 COL6A1 COL6A2 THBS3 SFPQ LTBP2 LTBP4 SCAI

4.61e-05395708gudmap_developingGonad_P2_epididymis_500
CoexpressionAtlasDevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000

COL4A3 COL4A4 COL6A1 COL6A2 THBS3 SFPQ HOXC9 LRP1 LTBP2 LTBP4 SCAI

5.57e-057977011gudmap_developingGonad_P2_epididymis_1000
CoexpressionAtlasDevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000

COL4A4 COL6A1 COL6A2 THBS3 SFPQ HOXC9 COL27A1 LRP1 LTBP2 LTBP4 SCAI

5.70e-057997011gudmap_developingGonad_e18.5_epididymis_1000
CoexpressionAtlasDevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_500

COL4A4 COL6A1 COL6A2 LTBP4

5.93e-0564704gudmap_developingGonad_e18.5_epididymis_500_k2
CoexpressionAtlasDevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000

COL6A1 COL6A2 THBS3 HOXC9 COL27A1 LTBP2

1.22e-04234706gudmap_developingGonad_e18.5_epididymis_1000_k5
CoexpressionAtlasStromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5

COL6A1 COL6A2 SYNPO2 WIPI1 FKBP9 LRP1 LTBP4 NRP1

1.45e-04466708GSM777050_500
CoexpressionAtlasDevelopingKidney_e11.5_metaneph mesench_emap-3843_k-means-cluster#2_top-relative-expression-ranked_1000

HOXC9 RRAGD C3orf80 CEP152

2.14e-0489704gudmap_developingKidney_e11.5_metaneph mesench_1000_k2
CoexpressionAtlasDevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_200

COL4A4 COL6A1 COL6A2 LTBP4 SCAI

2.21e-04166705gudmap_developingGonad_e18.5_epididymis_200
CoexpressionAtlasStromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3

COL6A1 COL6A2 FKBP9 LTBP4

2.98e-0497704GSM777043_100
CoexpressionAtlasProgenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_1000

COL6A1 COL6A2 ZBTB38 NFATC4 SNX18 FIBCD1 LRP1 LTBP2 NRP1 KLF2 CEMIP

3.44e-049817011PCBC_ctl_BronchSmoothMuscl_1000
CoexpressionAtlasDevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500

COL4A4 COL6A1 COL6A2 SFPQ LTBP2 LTBP4 SCAI

3.66e-04404707gudmap_developingGonad_e18.5_epididymis_500
ToppCellParenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

COL4A4 COL6A1 COL6A2 HOXC9 GLI1 C3orf80 LTBP4 BEGAIN

9.84e-1019771831c8d6e565bbdc37843ce871fe91845b0cc18a9f
ToppCellAdult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor

COL6A1 COL6A2 COL27A1 FIBCD1 PCSK1N LTBP2 LTBP4

8.22e-091647172ba57dce5f69a88f0d1e450b9780425e2d9ca7d4
ToppCellLA-01._Fibroblast_I|World / Chamber and Cluster_Paper

COL4A3 COL4A4 COL6A1 COL6A2 LRP1 LTBP2 LTBP4

2.03e-081877174ea486991f66c29728d127171a07b81404ec0b78
ToppCellCOVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type

COL4A4 COL6A1 COL6A2 SYNPO2 LRP1 LTBP2 LTBP4

2.11e-08188717fe361215f4ba841aa5e1e581fb56f2f4d3ccd201
ToppCellE16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass

CACNA1D COL6A1 COL6A2 WIPI1 GLI1 LRP1 LTBP4

2.11e-081887173f0f662be684e3a4c6652e636cc135a39a1d2790
ToppCelldroplet-Kidney-KIDNEY-30m-Mesenchymal-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A1 COL6A2 SYNPO2 THBS3 EFS LRP1 LGR6

2.19e-08189717544d95df910f1b276995624509a7e41b219baca0
ToppCellPND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

COL6A1 COL6A2 THBS3 EFS GLI1 LTBP4 NRP1

2.27e-08190717947807863a9b247c301c6cf63d6fd5a2c8018e66
ToppCellPND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

COL6A1 COL6A2 THBS3 SNX18 FKBP9 LRP1 LTBP4

2.35e-081917179f478f36a0b895e607e3bb77fa0f9f03cc0f33fc
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

COL6A2 SYNPO2 LRP1 C3orf80 LTBP2 LTBP4 CEMIP

2.53e-08193717dc8e62df6121ee99b156aca6b1b3ae555739b6f2
ToppCellPND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

COL6A1 COL6A2 THBS3 SNX18 FKBP9 LRP1 LTBP4

2.53e-08193717051f61156b0e2e95292b2d8377faf3190b50f264
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

COL6A2 SYNPO2 LRP1 C3orf80 LTBP2 LTBP4 CEMIP

2.53e-08193717e2ee077fd381bd906e6b4329f22e7d106e422a7f
ToppCell3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

COL6A1 COL6A2 SYNPO2 GLI1 PCSK1N LTBP2 LGR6

2.62e-0819471791205b22650e7ecdb72bb59348ce2530b76c532c
ToppCellLV-02._Fibroblast_II|LV / Chamber and Cluster_Paper

COL4A3 COL4A4 COL6A1 COL6A2 IRS2 LTBP2 LTBP4

2.62e-08194717014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCell3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

COL6A1 COL6A2 SYNPO2 GLI1 PCSK1N LTBP2 LGR6

2.62e-081947176e12a7da35be4c0ecf998ef94b8989b89d74b200
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

COL4A4 COL6A2 SYNPO2 NFATC4 LRP1 LTBP4 NRP1

2.62e-08194717e03ba6caed59fa64d4d9b042593469d4a6a3dc10
ToppCell3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

COL6A1 COL6A2 SYNPO2 GLI1 PCSK1N LTBP2 LGR6

2.62e-08194717c52f10140c66e8c0566421c3d535d5d92bf595e1
ToppCellCOVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type

COL4A3 COL4A4 COL6A1 COL6A2 LRP1 LTBP2 LTBP4

2.71e-08195717f423baa36ac7cdc383c033e35a7d17e6bf913323
ToppCellLA-02._Fibroblast_II|World / Chamber and Cluster_Paper

COL4A3 COL4A4 COL6A1 COL6A2 LRP1 LTBP2 LTBP4

2.71e-08195717a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCellPND03-Mesenchymal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CACNA1D COL6A1 COL6A2 COL27A1 FKBP9 LTBP2 LTBP4

2.91e-08197717e3053ef8f604b6892c21c03e12612b49d3d30f23
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

COL6A2 SYNPO2 LRP1 C3orf80 LTBP2 LTBP4 CEMIP

2.91e-081977174cf4e9553397cd8dee883dbec24f41bec41aff99
ToppCelldroplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A1 COL6A2 COL11A2 COL27A1 FKBP9 LRP1 CEMIP

3.01e-08198717d3a475be01657a03fcbb0ee0a246b1e90deacaa4
ToppCelldroplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

COL6A1 COL6A2 COL11A2 COL27A1 FKBP9 LRP1 CEMIP

3.01e-081987171beed34f469aad07e8f674f0b668d6e1e916403c
ToppCelldroplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A1 COL6A2 COL11A2 COL27A1 FKBP9 LRP1 CEMIP

3.01e-08198717985022c1722ab7b67675ebe814022a439e715b5e
ToppCellbackground-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells)

COL4A4 COL6A1 COL6A2 SYNPO2 COL27A1 LTBP2 LTBP4

3.01e-08198717bd11b0e9e80449aab979a02c1023e0638c431c7c
ToppCellproximal-mesenchymal-Fibromyocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

COL6A1 COL6A2 SYNPO2 GLI1 PCSK1N LTBP2 LGR6

3.23e-0820071737d9f46f727a31e8e94e348e4ddd71a2125ba01a
ToppCellproximal-3-mesenchymal-Fibromyocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

COL6A1 COL6A2 SYNPO2 GLI1 PCSK1N LTBP2 LGR6

3.23e-08200717ed6fbe61a04d29b105054f7058abe7469314b304
ToppCellControl_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type

COL6A1 COL6A2 SYNPO2 GLI1 LRP1 LTBP2 LTBP4

3.23e-08200717a799fc7bb83ad0524362cb5010df949741fb7bf3
ToppCellParenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

COL6A1 COL6A2 SYNPO2 LRP1 PCSK1N LTBP2 LTBP4

3.23e-08200717251fd2923f108cd2086961d897244b392c32ad54
ToppCellcellseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

COL6A1 COL6A2 SYNPO2 GLI1 PCSK1N LTBP2 LTBP4

3.23e-08200717b441b3771fb7d9ee7b7a104afc35e466aace2da2
ToppCellLung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

COL6A1 COL6A2 SYNPO2 SKOR1 PCSK1N LTBP2 LTBP4

3.23e-0820071707641f476cb1a131c2a50258b88cc13bb38c8379
ToppCellParenchyma_Control_(B.)-Stromal-TX-Fibroblasts-3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type

COL6A1 COL6A2 SYNPO2 SKOR1 PCSK1N LTBP2 LTBP4

3.23e-08200717343fa6ba1f52d816d2e41466f674ff8360aecd81
ToppCellproximal-mesenchymal-Fibromyocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

COL6A1 COL6A2 SYNPO2 GLI1 PCSK1N LTBP2 LGR6

3.23e-0820071749658e1b530de0dad16d45a1112bdf5329bb800d
ToppCellLung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

COL6A1 COL6A2 SYNPO2 SKOR1 PCSK1N LTBP2 LTBP4

3.23e-08200717d0c00cdd52c2e001aec9b935f4e981ba77d0386a
ToppCellTracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CACNA1D COL6A1 COL6A2 NFATC4 LRP1 LTBP2 NRP1

3.23e-0820071758b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

COL6A2 SYNPO2 LRP1 LTBP2 LTBP4 STAC

3.22e-071717165d31fc9b60329d4ae3c77e4ca679359d9314397d
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

COL4A4 COL6A2 SYNPO2 NFATC4 LTBP4 NRP1

4.08e-0717871678a0c6340001a77f5b2d890b6263f574af2e72da
ToppCell5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

COL6A1 COL6A2 SYNPO2 LTBP2 LGR6 LTBP4

4.50e-071817169c157de9d3403e092c907599f2a2c16db5b21131
ToppCell5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

COL6A1 COL6A2 SYNPO2 LTBP2 LGR6 LTBP4

4.50e-07181716b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

COL6A1 COL6A2 SYNPO2 LTBP2 LGR6 LTBP4

4.50e-07181716eea943fdcbef0bbaa8578f3296923e874893b405
ToppCellP28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

CACNA1D COL6A1 COL6A2 FKBP9 LRP1 LTBP4

4.65e-0718271619c5e3a9d9b3728303b682102e276adfe93aa759
ToppCelldroplet-Kidney-nan-21m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A1 COL6A2 EFS GLI1 LRP1 LTBP4

4.95e-071847163bffadb0cb2e0d825bdb6cfc5d23f5436cbc3efd
ToppCelldroplet-Kidney-nan-21m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A1 COL6A2 EFS GLI1 LRP1 LTBP4

5.11e-0718571633cc0e9d8b54cb7408b51235f2a70e044ebae04d
ToppCelldroplet-Kidney-nan-21m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A1 COL6A2 EFS GLI1 LRP1 LTBP4

5.11e-071857169954fc85b183c1cc45c3c24e3dadc7984ee6f649
ToppCell343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells)

PRR12 CACNA1D COL6A1 COL6A2 WIPI1 GLI1

5.28e-071867161bac7825c2fe3e6cdff65026b09b9ccaa40fa27f
ToppCell343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells)

PRR12 CACNA1D COL6A1 COL6A2 WIPI1 GLI1

5.28e-0718671659db239f1864a5d4f1570c93219dbd7ac5b6db35
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor

CACNA1D COL6A1 COL27A1 LTBP2 NRP1 CEMIP

5.44e-07187716e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCelldroplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

COL4A3 COL4A4 COL6A1 ISLR2 COL6A2 GLI1

5.44e-07187716ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9
ToppCellfacs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A1 COL6A2 SYNPO2 NFATC4 PCSK1N STAC

5.79e-07189716a5306561026e4dfcc39beeb785e5108ac595d136
ToppCelldroplet-Lung-LUNG-1m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL4A3 COL6A1 COL6A2 THBS3 GLI1 LTBP4

5.79e-07189716f0a2d4ef9896d764971ebbc6952510c128bb76e8
ToppCellfacs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A1 COL6A2 EFS NFATC4 FKBP9 IGDCC3

5.79e-071897161db5dd1ef2a65251af2d5696622d1dd9c4ae2b55
ToppCellfacs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A1 COL6A2 EFS NFATC4 FKBP9 IGDCC3

5.79e-07189716bfb1c183a8a2752a2368b74150e66181c6a9da48
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

COL6A1 COL6A2 NFATC4 LRP1 LTBP2 LTBP4

5.79e-07189716d531399749409d614adca13d181830c6e3287508
ToppCellfacs-Kidney-nan-3m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A1 COL6A2 SYNPO2 NFATC4 PCSK1N STAC

5.79e-07189716381058f55908f84375b54601d617389ef43ab855
ToppCelldroplet-Limb_Muscle-nan-21m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A1 ISLR2 COL6A2 THBS3 LRP1 LTBP4

5.79e-071897160a8b827bba1efd885ad6c06929251c741dc3a541
ToppCelldroplet-Limb_Muscle-nan-21m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A1 COL6A2 THBS3 FKBP9 LRP1 LTBP4

5.79e-0718971656f43e00d81cf3cdf0c39f8d7120f5beab72e258
ToppCelldroplet-Lung-LUNG-1m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL4A3 COL6A1 COL6A2 THBS3 GLI1 LTBP4

5.79e-07189716378f26f751ab4b470948c35dd8347de72dd12ff7
ToppCelldroplet-Lung-LUNG-1m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL4A3 COL4A4 CACNA1D SYNPO2 THBS3 LGR6

5.79e-071897164dc32b463546bbe7250dddd281b92ad17ec22da1
ToppCelldroplet-Lung-LUNG-1m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL4A3 COL4A4 CACNA1D SYNPO2 THBS3 LGR6

5.79e-071897160d06bf0d7191d13a1c4f30a7881e7ea1093bfd6f
ToppCellfacs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A1 COL6A2 SYNPO2 NFATC4 PCSK1N STAC

5.79e-07189716302b950a6ad578f8aeff7ea6fd15fe631225287d
ToppCellfacs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A1 COL6A2 EFS NFATC4 FKBP9 IGDCC3

5.79e-0718971614833feea8f80744a06ece73f813eaeff8c4dd61
ToppCellMatrixFB-Fibroblast-C|MatrixFB / shred on cell class and cell subclass (v4)

COL4A4 COL6A1 COL6A2 LTBP4 NRP1 KLF2

5.97e-07190716d0106f7a21292f0b96ce4337ec3efbb1bd78dd0a
ToppCellPND07-28-samps-Mesenchymal-Myofibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass

COL6A1 COL6A2 SYNPO2 THBS3 LTBP2 LTBP4

6.16e-071917169bbafdf316c1fa3a9f1ee30d41dd7158b5c97279
ToppCellfacs-Lung-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

COL6A1 COL6A2 SYNPO2 IRS2 LTBP2 LGR6

6.16e-07191716fd8331c7abdd999f55ba43d307945c6abfccbf84
ToppCellLV-02._Fibroblast_II|World / Chamber and Cluster_Paper

COL4A3 COL4A4 COL6A1 COL6A2 LTBP2 LTBP4

6.16e-07191716d36565257ccba8c1bbed2c1c01be66a9cbb5f834
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

COL4A4 SYNPO2 COL27A1 LRP1 LTBP4 NRP1

6.35e-071927169093a9e94a25682d109a7f6edc256a25a61103a0
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

COL4A4 COL6A2 SYNPO2 LRP1 LTBP4 NRP1

6.35e-07192716bc84b9ce01b4d826a682842ab8a395dac9b91183
ToppCellPND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

COL6A1 COL6A2 GLI1 FKBP9 LTBP2 LTBP4

6.35e-07192716ad48c941a3ddfd9a5146bafc2209da577bb50531
ToppCellfacs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A1 COL6A2 THBS3 GLI1 LRP1 LTBP4

6.35e-07192716a2c31390da4962bda9a936470b0b68fa1f5d47d1
ToppCellPND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CACNA1D COL6A1 COL6A2 FKBP9 LRP1 LTBP4

6.35e-0719271625492568f9cbe097b7bb1db50d8b817c80ea87d7
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

COL4A4 SYNPO2 COL27A1 LRP1 LTBP4 NRP1

6.35e-071927169ed5d49621ec1aa01716dc369bba1450b5f015f5
ToppCellfacs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

COL6A1 COL6A2 THBS3 GLI1 LRP1 LTBP4

6.35e-071927167b48df661f61ce494bf6f0b9a74b0422e29c24bf
ToppCellfacs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A1 COL6A2 THBS3 GLI1 LRP1 LTBP4

6.35e-07192716eeab1cef7c36ae824381952c5b2c982368c379fd
ToppCellCOVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type

COL4A3 COL4A4 COL6A1 COL6A2 LRP1 LTBP2

6.35e-0719271660b1312e84f6d6448365a952469c506c00b5fe93
ToppCellPND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CACNA1D COL6A1 COL6A2 FKBP9 LRP1 LTBP4

6.35e-07192716de9c1536d5aee86f9c62acbc54ca8fa581c00f17
ToppCelldroplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

COL4A3 COL6A1 COL6A2 THBS3 GLI1 LTBP4

6.35e-07192716f9fb24457999dc9e751a099d7f995543b9330ad4
ToppCellPND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

COL6A1 COL6A2 GLI1 FKBP9 LTBP2 LTBP4

6.35e-0719271619b94f254d51b9bda3d9b7c6f85e27ecb58409c8
ToppCellP03-Mesenchymal-mesenchymal_fibroblast|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

CACNA1D COL6A1 COL6A2 FKBP9 LRP1 LTBP4

6.35e-07192716e79f2253e084a9ab9afcaf7ec42a5012ade42d36
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

COL4A4 COL6A2 SYNPO2 LRP1 LTBP4 NRP1

6.35e-071927160ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1
ToppCelldroplet-Lung-immune-endo-depleted-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A1 COL6A2 THBS3 NFATC4 GLI1 LTBP4

6.55e-07193716858a186804b36d45957238d3d3eed2768b961641
ToppCellfacs-MAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A1 COL6A2 THBS3 FKBP9 LRP1 LTBP4

6.55e-07193716f95b95c58a6edb8a03dd15ae166f47f9f33d8bd6
ToppCelldroplet-Limb_Muscle-nan-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A1 COL6A2 THBS3 FKBP9 LRP1 LTBP4

6.55e-07193716428b1a3ad87dff7f65de5161d40f102572a9341b
ToppCelldroplet-Lung-immune-endo-depleted-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A1 COL6A2 THBS3 NFATC4 GLI1 LTBP4

6.55e-071937167865e7ec0a288249540d4cba94ae01c93e1b617c
ToppCellLV-01._Fibroblast_I|LV / Chamber and Cluster_Paper

COL4A3 COL4A4 COL6A1 COL6A2 LTBP2 LTBP4

6.55e-07193716dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCelldroplet-Limb_Muscle-nan-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A1 COL6A2 THBS3 FKBP9 LRP1 LTBP4

6.55e-07193716eff718664fe0aaf89050efd9cc7b6dfb1df46666
ToppCellfacs-MAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A1 COL6A2 THBS3 FKBP9 LRP1 LTBP4

6.55e-0719371685faf6c5ce4769615a4eca036e2ba307e176bb52
ToppCellfacs-Trachea-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

COL6A1 COL6A2 THBS3 FKBP9 LRP1 LTBP4

6.55e-0719371625248b8e65d558b1a96a87c93e3e5b4c0ba168fe
ToppCellfacs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

COL6A1 COL6A2 THBS3 FKBP9 LRP1 LTBP4

6.55e-07193716f1f1097204e07a7bed416425b8256942038a734f
ToppCellfacs-MAT-Fat-3m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A1 COL6A2 THBS3 FKBP9 LRP1 LTBP4

6.55e-07193716110a7d2ba7d066c2be38be98b643b76c520dd980
ToppCelldroplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

COL6A1 COL6A2 THBS3 EFS GLI1 LTBP4

6.75e-071947165594f7437448cb4b37d2d100f44d30c4a367df26
ToppCelldroplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A1 COL6A2 THBS3 FKBP9 LRP1 LTBP4

6.75e-07194716da926441053b499cb5107ccb116fb1b3844d82b7
ToppCellMesenchymal_cells-Arteriolar_fibro.|World / Lineage and Cell class

COL6A1 COL6A2 THBS3 FKBP9 LRP1 LTBP4

6.75e-07194716c1e8923a50b4138a1e4c054c0c17b7f7122aa8a9
ToppCellCOVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type

COL4A4 COL6A1 COL6A2 LRP1 LTBP2 LTBP4

6.75e-07194716d91c9f2ec47319051fc398320693fddbe8bbd4d6
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

COL6A1 COL6A2 SYNPO2 LRP1 LTBP2 LTBP4

6.75e-0719471602b8102be9414d6964cd71019613edff6d88b893
ToppCelldroplet-Trachea-nan-3m-Mesenchymal-mesenchymal_progenitor_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A1 COL6A2 THBS3 LRP1 LTBP4 NRP1

6.75e-071947163d25d6ebec8d1b6001f602257cd15b3ba04cf0c1
ToppCelldroplet-Fat-BAT+GAT+MAT-30m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A1 COL6A2 THBS3 FKBP9 LRP1 LTBP4

6.75e-0719471654a7f693966b5c02f6b248950ddb5fa32af3ae67
ToppCellLPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CACNA1D COL6A1 COL6A2 SYNPO2 LRP1 LTBP4

6.75e-071947166e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCelldroplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A1 COL6A2 THBS3 FKBP9 LRP1 LTBP4

6.75e-07194716f34b3bbdebf56f66ff499e390e5515a4a4093f90
ToppCellLA-02._Fibroblast_II|LA / Chamber and Cluster_Paper

COL4A3 COL4A4 COL6A2 LRP1 LTBP2 LTBP4

6.75e-07194716234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCellASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq

COL6A1 COL6A2 SYNPO2 LTBP2 LTBP4 NRP1

6.95e-071957162b156163975d9a3d3fda1402acd9831d0fdc9e25
ToppCellE17.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

COL6A1 COL6A2 SYNPO2 COL27A1 LTBP2 LGR6

6.95e-071957161daddd801bd4596fffbdb822fc326d5127c96004
ComputationalNeighborhood of CDH11

COL6A1 COL6A2 FKBP9

1.58e-0425463GNF2_CDH11
DrugGK-101

COL4A3 COL6A1 COL6A2 COL11A2 COL27A1

8.94e-0836715CID000161853
DrugMadecassol

COL4A3 COL6A1 COL6A2 COL11A2 COL27A1

3.17e-0746715CID000108062
Drugd-indobufen

COL4A3 COL6A1 COL6A2 COL11A2 COL27A1

4.86e-0750715CID000044562
Drugridogrel

COL4A3 COL6A1 COL6A2 COL11A2 COL27A1

5.93e-0752715CID005362391
DrugNSC49633

COL4A3 COL6A1 COL6A2 COL11A2 COL27A1

6.53e-0753715CID000023340
Drugprochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HT_HG-U133A_EA

CNNM1 WIPI1 PER1 CEP152 IRS2 KLF2 CEMIP

1.14e-06173717995_UP
DrugAC1L1C2F

COL4A3 COL6A1 COL6A2 COL11A2 EFS COL27A1

1.23e-06110716CID000001711
DrugAC1LAKND

COL4A3 COL6A1 COL6A2 COL11A2 COL27A1

1.44e-0662715CID000470146
DrugPimozide [2062-78-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A

COL6A1 EFS NFATC4 PER1 IRS2 KLF2 CEMIP

1.86e-061867173178_UP
DrugClozapine [5786-21-0]; Up 200; 12.2uM; PC3; HT_HG-U133A

TFEB CACNA1D COL6A1 L3MBTL1 PER1 CHD3 TBX6

2.37e-061937174670_UP
DrugFlumethasone [2135-17-3]; Up 200; 9.8uM; PC3; HT_HG-U133A

CACNA1D PRR36 PER1 CEP152 IRS2 LTBP4 BEGAIN

2.54e-061957173712_UP
DrugSelara

COL4A3 COL6A1 COL6A2 COL11A2 NSFL1C COL27A1

2.60e-06125716CID000150310
DrugSolasodine [126-17-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A

TFEB COL6A1 RRAGD PRR36 ESRRA SNX15 SH2B1

2.63e-061967173830_DN
DrugBAPN

COL4A3 COL6A1 COL6A2 COL11A2 COL27A1

2.84e-0671715CID000001647
Drugmalotilate

COL4A3 COL6A1 COL6A2 COL11A2 COL27A1

2.84e-0671715CID000004006
DrugAC1NMZ1B

COL4A3 COL6A1 COL6A2 COL11A2 COL27A1

3.72e-0675715CID005034185
Drugstrontium ranelate

COL4A3 COL6A1 COL6A2 COL11A2 COL27A1

4.24e-0677715CID006918182
Drugcandesartan cilexetil

COL4A3 COL6A1 COL6A2 COL11A2 COL27A1 VPS51

6.13e-06145716CID000002540
Drughalofuginone lactate

COL4A3 COL6A1 COL6A2 COL11A2 COL27A1

6.91e-0685715CID000062891
DrugAC1Q6PCP

COL4A3 TFEB COL6A1 COL6A2 COL11A2 COL27A1 ESRRA

7.52e-06230717CID000005267
Drugthioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA

WIPI1 PRR36 PER1 IRS2 KLF2 CEMIP

9.32e-061567161010_UP
Drug4-hydroxyproline

COL4A3 COL6A1 COL6A2 COL11A2 COL27A1

9.65e-0691715CID000000825
Drugfelodipine; Up 200; 10uM; MCF7; HT_HG-U133A_EA

SFPQ PRR36 PER1 IRS2 KLF2 CEMIP

1.52e-05170716965_UP
Drugticlopidine

COL4A3 COL6A1 COL6A2 COL11A2 COL27A1

1.77e-05103715CID000005472
DrugZuclopenthixol hydrochloride [633-59-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A

THBS3 WIPI1 KBTBD11 IRS2 KLF2 CEMIP

2.10e-051807167356_UP
Drug17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A

COL6A1 THBS3 ESRRA CHD3 IRS2 LTBP2

2.31e-051837166985_UP
Drughydroxylysine

COL4A3 COL6A1 COL6A2 COL11A2 COL27A1

2.32e-05109715CID000001029
DrugPPACK

COL4A3 COL6A1 COL6A2 COL11A2 COL27A1

2.76e-05113715CID003036757
DrugAC1L9732

COL4A3 COL6A1 COL6A2 COL11A2 COL27A1

2.88e-05114715CID000439300
DrugFludrocortisone acetate [514-36-3]; Up 200; 9.4uM; HL60; HT_HG-U133A

COL4A3 PER1 CHD3 IRS2 NRP1 TBX6

2.93e-051917162368_UP
Drug2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A

COL6A1 WIPI1 ESRRA KLF2 CEMIP TBX6

2.93e-051917161665_UP
DrugTranilast sodium

COL4A3 COL6A1 COL6A2 COL11A2 COL27A1

3.01e-05115715CID000005527
DrugDimethisoquin hydrochloride [2773-92-4]; Up 200; 13uM; MCF7; HT_HG-U133A

COL4A3 TFEB L3MBTL1 PRR36 NFATC4 LTBP2

3.02e-051927162807_UP
DrugTriamcinolone [124-94-7]; Up 200; 10.2uM; PC3; HT_HG-U133A

THBS3 ZBTB38 PER1 ANKMY1 CEP152 IRS2

3.11e-051937162078_UP
DrugFluvastatin sodium salt [93957-55-2]; Up 200; 9.2uM; MCF7; HT_HG-U133A

COL6A1 IRS2 LTBP2 TEX13B KLF2 TBX6

3.11e-051937163370_UP
DrugMethylhydantoin-5-(L) [40856-73-3]; Up 200; 35uM; MCF7; HT_HG-U133A

TFEB EFS NFATC4 LTBP2 BEGAIN TBX6

3.30e-051957163378_UP
DrugBromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A

COL6A1 THBS3 EFS IRS2 LTBP4 TBX6

3.30e-051957165665_UP
DrugFinasteride [98319-26-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A

COL6A1 L3MBTL1 PRR36 NFATC4 LTBP4 BEGAIN

3.39e-051967166062_UP
DrugPNU-0230031 [267429-39-0]; Up 200; 10uM; PC3; HT_HG-U133A

TFEB L3MBTL1 PRR36 NFATC4 LRP1 TBX6

3.39e-051967163732_UP
DrugHeliotrine [303-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A

CACNA1D COL6A1 CHD3 IRS2 LTBP2 TBX6

3.39e-051967164739_DN
Drugrotenone; Down 200; 1uM; PC3; HT_HG-U133A

COL6A1 L3MBTL1 LRP1 BEGAIN NRP1 CEMIP

3.49e-051977165948_DN
DrugXamoterol hemifumarate [73210-73-8]; Down 200; 5uM; MCF7; HT_HG-U133A

CACNA1D THBS3 L3MBTL1 CHD3 LTBP4 SH2B1

3.49e-051977163401_DN
DrugRibostamycin sulfate salt [53797-35-6]; Up 200; 7.2uM; MCF7; HT_HG-U133A

COL6A1 WIPI1 PRR36 IRS2 KLF2 TBX6

3.59e-051987166765_UP
DrugQuinethazone [73-49-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A

COL4A3 COL6A2 L3MBTL1 NFATC4 STAC TBX6

3.59e-051987164351_UP
DrugDextromethorphan hydrobromide monohydrate [6700-34-1]; Up 200; 10.8uM; MCF7; HT_HG-U133A

COL6A1 L3MBTL1 ANKMY1 LTBP2 BEGAIN TBX6

3.59e-051987162636_UP
DrugEdrophonium chloride [116-38-1]; Up 200; 19.8uM; MCF7; HT_HG-U133A

TFEB ESRRA PER1 CEP152 IRS2 TBX6

3.59e-051987161519_UP
Drugdexamethasone; Up 200; 1uM; MCF7; HG-U133A

COL6A2 THBS3 WIPI1 L3MBTL1 PER1 NRP1

3.59e-05198716123_UP
DrugMethimazole [60-56-0]; Down 200; 35uM; MCF7; HT_HG-U133A

TFEB COL6A1 THBS3 KBTBD11 PER1 SH2B1

3.80e-052007164372_DN
DrugDimaprit dihydrochloride [23256-33-9]; Up 200; 17uM; MCF7; HT_HG-U133A

CNNM1 COL6A1 THBS3 CHD3 IRS2 KLF2

3.80e-052007167480_UP
DrugDMSe

COL4A3 COL6A1 COL6A2 COL11A2 COL27A1

5.82e-05132715CID000020796
Drugpirfenidone

COL4A3 COL6A1 COL6A2 COL11A2 COL27A1

7.18e-05138715CID000040632
DrugDL-penicillamine

COL4A3 COL6A1 COL6A2 COL11A2 COL27A1

7.43e-05139715CID000004727
DrugPCR 4099

COL4A3 COL6A1 COL6A2 COL11A2 COL27A1

7.43e-05139715CID000002806
DrugSuloctidil [54063-56-8]; Up 200; 11.8uM; MCF7; HT_HG-U133A

WIPI1 PER1 IRS2 KLF2 CEMIP

1.32e-041577152651_UP
DrugTerfenadine [50679-08-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A

COL6A1 PER1 IRS2 KLF2 CEMIP

1.48e-041617152227_UP
DrugMetixene hydrochloride [1553-34-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A

WIPI1 IRS2 LTBP4 KLF2 CEMIP

1.53e-041627155018_UP
DrugL-lysyl-L-lysyl-L-lysine

COL4A3 COL6A1 COL6A2 COL11A2 COL27A1

1.53e-04162715CID000072363
Drugthioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A

WIPI1 PRR36 IRS2 KLF2 CEMIP

1.66e-041657155227_UP
Drugprochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HT_HG-U133A

WIPI1 PRR36 IRS2 KLF2 CEMIP

1.76e-041677155212_UP
Drugtrifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A

WIPI1 ANKMY1 IRS2 KLF2 CEMIP

1.81e-041687151649_UP
DrugCephaeline dihydrochloride heptahydrate [6487-30-5]; Down 200; 6uM; HL60; HT_HG-U133A

L3MBTL1 RRAGD KBTBD11 PDZD8 CEP152

1.97e-041717152429_DN
Drugkhellin

COL4A3 COL6A1 COL6A2 COL11A2 COL27A1

1.97e-04171715CID000003828
DrugAC1L9HPX

COL6A1 COL6A2 COL11A2 COL27A1

1.97e-0492714CID000445279
DrugThonzonium bromide [553-08-2]; Up 200; 6.8uM; PC3; HT_HG-U133A

WIPI1 EFS ANKMY1 IRS2 KLF2

2.08e-041737154617_UP
Drugfluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A

WIPI1 PRR36 IRS2 KLF2 CEMIP

2.37e-041787155234_UP
DrugAC1L1DD6

COL4A3 COL6A1 COL6A2 COL11A2 COL27A1

2.43e-04179715CID000002299
Drugtrifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A

WIPI1 RRAGD IRS2 KLF2 CEMIP

2.49e-041807155584_UP
DrugBenzethonium chloride [121-54-0]; Up 200; 9uM; MCF7; HT_HG-U133A

L3MBTL1 NFATC4 IRS2 LTBP4 KLF2

2.49e-041807156070_UP
DrugRifabutin [72559-06-9]; Up 200; 4.8uM; MCF7; HT_HG-U133A

COL4A3 TFEB RRAGD NFATC4 IRS2

2.56e-041817154349_UP
Drugsilibinin

COL4A3 CNNM1 COL6A1 COL6A2 COL11A2 COL27A1

2.64e-04285716CID000005213
DrugPcme

COL6A1 COL6A2

2.65e-048712CID000169849
DrugCloperastine hydrochloride [14984-68-0]; Up 200; 11uM; MCF7; HT_HG-U133A

COL6A1 L3MBTL1 PRR36 IRS2 KLF2

2.69e-041837154732_UP
DrugTrimipramine maleate salt [521-78-8]; Up 200; 9.8uM; MCF7; HT_HG-U133A

WIPI1 PER1 IRS2 KLF2 CEMIP

2.90e-041867154163_UP
DrugEthaverine hydrochloride [985-13-7]; Up 200; 9.2uM; HL60; HT_HG-U133A

CNNM1 L3MBTL1 LRP1 TEX13B TBX6

2.97e-041877153037_UP
DrugRapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A

COL6A1 PRR36 NFATC4 CEP152 CEMIP

2.97e-041877151242_UP
DrugThonzonium bromide [553-08-2]; Up 200; 6.8uM; MCF7; HT_HG-U133A

COL6A1 PER1 IRS2 BEGAIN KLF2

2.97e-041877155678_UP
DrugPropofol [2078-54-8]; Up 200; 22.4uM; MCF7; HT_HG-U133A

COL4A3 L3MBTL1 PER1 IRS2 KLF2

2.97e-041877153386_UP
Drugchondroitin sulfate

COL4A3 COL6A1 COL6A2 THBS3 COL11A2 COL27A1 NRP1

3.01e-04413717CID000024766
DrugAlexidine dihydrochloride [22573-93-9]; Up 200; 6.8uM; PC3; HT_HG-U133A

L3MBTL1 PER1 IRS2 KLF2 TBX6

3.05e-041887157397_UP
Drug12(S)-hydroxyeicosatetraenoic acid

COL4A3 COL6A1 COL6A2 COL11A2 COL27A1

3.12e-04189715CID000001413
Drugionomycin calcium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA

COL4A3 WIPI1 L3MBTL1 PER1 TBX6

3.12e-04189715882_UP
Drug6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine

PRR12 PRR36 PCSK1N STAC

3.16e-04104714ctd:C000595015
Drugfoscarnet

COL4A3 COL6A1 COL6A2 COL11A2 COL27A1

3.20e-04190715CID000003414
DrugRapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A

COL6A1 CEP152 IRS2 CEMIP TBX6

3.20e-041907155602_UP
DrugRimexolone [49697-38-3]; Up 200; 10.8uM; HL60; HT_HG-U133A

CNNM1 COL6A1 PER1 PCSK1N TBX6

3.28e-041917152955_UP
DrugCP-320650-01 [172079-28-6]; Up 200; 10uM; MCF7; HT_HG-U133A

COL6A1 ANKMY1 IRS2 STAC CEMIP

3.28e-041917153905_UP
DrugDienestrol [84-17-3]; Up 200; 15uM; MCF7; HT_HG-U133A

CNNM1 PER1 IRS2 KLF2 CEMIP

3.28e-041917153448_UP
DrugDimethisoquin hydrochloride [2773-92-4]; Up 200; 13uM; MCF7; HT_HG-U133A

THBS3 PER1 LRP1 IRS2 KLF2

3.28e-041917154791_UP
DrugMebhydroline 1,5-naphtalenedisulfonate [6153-33-9]; Up 200; 4.8uM; MCF7; HT_HG-U133A

COL4A4 TFEB THBS3 L3MBTL1 KBTBD11

3.44e-041937154795_UP
DrugSimvastatin [79902-63-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A

COL4A3 TFEB PER1 IRS2 KLF2

3.44e-041937153340_UP
DrugSerotonin hydrochloride [153-98-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A

COL6A1 KBTBD11 ANKMY1 LTBP4 SH2B1

3.44e-041937155633_DN
Drugcarmustine; Down 200; 100uM; PC3; HT_HG-U133A

L3MBTL1 ESRRA KBTBD11 SGF29 CEMIP

3.52e-041947156883_DN
DrugEpivincamine [6835-99-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A

CACNA1D COL6A1 L3MBTL1 KBTBD11 CEMIP

3.52e-041947152775_UP
DrugDropropizine (R,S) [17692-31-8]; Up 200; 17uM; MCF7; HT_HG-U133A

COL4A3 TFEB CACNA1D IRS2 BEGAIN

3.52e-041947155531_UP
DrugYohimbinic acid monohydrate [27801-27-2]; Up 200; 11.2uM; PC3; HT_HG-U133A

TFEB L3MBTL1 LTBP4 NRP1 TBX6

3.52e-041947154082_UP
DrugPHA-00745360 [351320-33-7]; Down 200; 10uM; PC3; HT_HG-U133A

TFEB CNNM1 L3MBTL1 ESRRA CHD3

3.52e-041947154559_DN
DrugS(-)Eticlopride hydrochloride [97612-24-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A

COL6A1 L3MBTL1 NFATC4 IRS2 LTBP4

3.52e-041947155695_UP
DrugUngerine nitrate; Down 200; 10.2uM; MCF7; HT_HG-U133A

COL6A1 WIPI1 ANKMY1 IRS2 CEMIP

3.52e-041947156076_DN
DrugBudesonide [51333-22-3]; Up 200; 9.2uM; PC3; HT_HG-U133A

COL6A1 L3MBTL1 PER1 TEX13B LTBP4

3.61e-041957156330_UP
DrugTrimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A

L3MBTL1 PRR36 KBTBD11 LTBP4 SH2B1

3.61e-041957154180_DN
Diseasebenign familial hematuria (is_implicated_in)

COL4A3 COL4A4

5.23e-062682DOID:0111365 (is_implicated_in)
DiseaseAlport syndrome, recessive type

COL4A3 COL4A4

5.23e-062682C2931254
DiseaseAlport syndrome, dominant type

COL4A3 COL4A4

5.23e-062682C2931253
DiseaseALPORT SYNDROME 2, AUTOSOMAL RECESSIVE

COL4A3 COL4A4

5.23e-062682C4746745
Diseaseautosomal recessive Alport syndrome (is_implicated_in)

COL4A3 COL4A4

5.23e-062682DOID:0110033 (is_implicated_in)
DiseaseThin basement membrane disease

COL4A3 COL4A4

5.23e-062682C0403440
DiseaseBenign familial hematuria

COL4A3 COL4A4

5.23e-062682cv:C0241908
Diseaseautosomal recessive Alport syndrome (implicated_via_orthology)

COL4A3 COL4A4

1.57e-053682DOID:0110033 (implicated_via_orthology)
DiseaseAlport syndrome

COL4A3 COL4A4

1.57e-053682cv:C1567741
DiseaseCollagen IV-related nephropathies

COL4A3 COL4A4

1.57e-053682cv:CN076135
DiseaseHematuria, Benign Familial

COL4A3 COL4A4

3.13e-054682C0241908
DiseaseBethlem myopathy (is_implicated_in)

COL6A1 COL6A2

3.13e-054682DOID:0050663 (is_implicated_in)
DiseaseUllrich congenital muscular dystrophy

COL6A1 COL6A2

3.13e-054682cv:C4551860
DiseaseBethlem myopathy

COL6A1 COL6A2

3.13e-054682cv:C1834674
DiseaseBETHLEM MYOPATHY 1

COL6A1 COL6A2

3.13e-054682C1834674
DiseaseUllrich congenital muscular dystrophy (is_implicated_in)

COL6A1 COL6A2

3.13e-054682DOID:0050558 (is_implicated_in)
DiseaseMRNA-decapping enzyme 1A measurement

COL6A1 COL6A2

3.13e-054682EFO_0802757
DiseaseUllrich congenital muscular dystrophy 1

COL6A1 COL6A2

3.13e-054682C0410179
DiseaseAlport Syndrome

COL4A3 COL4A4

3.13e-054682C1567741
DiseaseAlport Syndrome, X-Linked

COL4A3 COL4A4

5.21e-055682C1567742
DiseaseAlport Syndrome, Autosomal Dominant

COL4A3 COL4A4

5.21e-055682C1567743
DiseaseAlport Syndrome, Autosomal Recessive

COL4A3 COL4A4

5.21e-055682C1567744
Diseasehypertensive nephropathy

COL4A3 COL4A4

7.80e-056682C0848548
Diseaserefractive error

COL4A3 COL4A4 CACNA1D ZBTB38 ARHGAP27 SGF29

1.07e-04326686MONDO_0004892
DiseaseMiT family translocation renal cell carcinoma

TFEB SFPQ

1.09e-047682C4518356
Diseaseresponse to ondansetron, QT interval

COL6A1 REPS1

2.84e-0411682EFO_0004682, EFO_0020997
Diseasecollagen disease (implicated_via_orthology)

COL4A3 COL4A4

3.40e-0412682DOID:854 (implicated_via_orthology)
Diseasecentral corneal thickness

COL4A3 COL6A1 COL6A2 ZBTB38 REPS1

7.41e-04309685EFO_0005213
Diseaseurate measurement

COL4A4 THBS3 RRAGD GLI1 LRP1 CHD3 VPS51 CEMIP

1.03e-03895688EFO_0004531
Diseasecarpal tunnel syndrome

THBS3 COL11A2 ZBTB38

1.15e-0389683EFO_0004143
DiseaseRenal glomerular disease

COL4A3 COL4A4

1.28e-0323682C0268731
DiseaseGlomerulopathy Assessment

COL4A3 COL4A4

1.28e-0323682C4521256
Diseasehematocrit

COL4A3 PRR12 THBS3 ZBTB38 CHD3 IRS2 LTBP4 TBX6

2.22e-031011688EFO_0004348

Protein segments in the cluster

PeptideGeneStartEntry
PEEGGDEGGSGYSPP

CEP152

121

O94986
EGAGPYVDLDEAGGS

COPS9

11

Q8WXC6
ESYGSEKGAPGDPGL

COL4A3

281

Q01955
GDKGEPGYSEGTRPG

COL4A3

1051

Q01955
PIYDDDPSLEGGVNG

DNMT1

441

P26358
PGYAPSEGGDGDRLG

BEGAIN

511

Q9BUH8
DPGFPGRYGETGDVG

COL4A4

371

P53420
LAGDVDERGGYDPPT

CEMIP

561

Q8WUJ3
KSYPAGGEAGGEEPE

ISLR2

656

Q6UXK2
DAYPGRRADCGPGEG

HOXC9

121

P31274
FRLEPGGSPSDEGDY

IGDCC3

101

Q8IVU1
EASEAGRPPGLETYG

LGR6

881

Q9HBX8
YEGGEPDDVGGLLDA

LRP1

4476

Q07954
PPGSSEGSEGEDDDY

GPATCH1

196

Q9BRR8
EGADGGGDPRPGESF

PER1

6

O15534
YDDGPAGPDAEEAGD

PCSK1N

171

Q9UHG2
TEYEDGGAPAGDGEA

L3MBTL1

126

Q9Y468
YGGGRDEEPSGAAPE

PDZD8

61

Q8NEN9
RFQAEEYGEGGTDPP

COL11A2

326

P13942
EGGGREDAPAQEPSY

GLI1

911

P08151
AGGGYRLGAAPEEES

NSFL1C

151

Q9UNZ2
ETGSTPGYEGEGEGD

NRP1

826

O14786
GYGEAGVDGEVPGSA

FKBP9

451

O95302
ETPPARDGGGGGEFY

IRS2

526

Q9Y4H2
GYRGDEGPPGSEGAR

COL6A1

476

P12109
GYPGLKGDEGEAGDP

COL6A1

541

P12109
GGSYVFQSDEGPEPE

CHD3

306

Q12873
YPGEAGSPGERGDQG

COL6A2

356

P12110
GGVAAEPDGGEGRYP

C3orf80

231

F5H4A9
GPGVETYPDGSQDVG

ANKMY1

81

Q9P2S6
VGDRGDRGEPGDPGY

COL27A1

1351

Q8IZC6
GYGGPKVEGDPEGRE

EFS

346

O43281
DGGYRPSPLGDSCED

LTBP2

1121

Q14767
GQSPGEEGYVPDADI

MBOAT4

276

Q96T53
FEDDGGPYGESEAPA

LTBP4

1476

Q8N2S1
GVGLFSVDPEEDGYP

FIBCD1

351

Q8N539
YGDGPDSSDADPDSG

RRAGD

31

Q9NQL2
EYEAGRAGPGGGAER

ESRRA

361

P11474
QDFGPGYSDEEPDPG

CACNA1D

2131

Q01668
ELPYDPVDTEGFGEG

NOA1

51

Q8NC60
VGGGSPEREEVGAGY

OTUD5

161

Q96G74
IEVYDPGSEDPRGTG

FAM83G

71

A6ND36
ERSPPSGGGGYELRE

SKOR1

746

P84550
GEPEGGEGDQPLSGY

SH2B1

511

Q9NRF2
SFGGREDEGPPGYPE

TFEB

401

P19484
GDQPGEVGYSGSPAE

REPS1

381

Q96D71
GYGPGEGAPEQEKSR

NFATC4

846

Q14934
EELRGYDSGPEGGAA

PRR36

1131

Q9H6K5
PEEDYSPVGSFGEPG

ARHGAP27

371

Q6ZUM4
GGAADDYGKAGPPED

PRR12

956

Q9ULL5
SPSRGGPDDDGGYTA

RBMXL2

121

O75526
EPFESYGELRGAAPG

RBMXL2

281

O75526
YPGTEPGAAGESESE

KBTBD11

11

O94819
PNETLSGRGAPGDYE

ATF6B

626

Q99941
PPGFGGTGEDYSEEG

CNNM1

306

Q9NRU3
GTPAGYGRGREEYEG

SFPQ

686

P23246
YGLSEGEAAGRPAGP

VPS51

41

Q9UID3
RGTGAGGDSGPEEDY

SYNPO2

721

Q9UMS6
GAIPASGDYVARPGD

SGF29

146

Q96ES7
DEPGALGSGAYPDLD

SNX18

166

Q96RF0
VPEEANGPGGGYDLR

STAC

236

Q99469
EEEDGEGGPTPAYLS

SNX15

256

Q9NRS6
GVFPTGRSDSEGPYD

SCAI

371

Q8N9R8
RGPEPAATEAYGSGD

TBX6

291

O95947
GDDDNDGIPDYVPPG

THBS3

661

P49746
GGVPAGSDEYEDECP

RIOK2

436

Q9BVS4
FLGSGEDGEGAPDPR

STRN4

321

Q9NRL3
GEIPEESNYVADPGG

ZBTB38

786

Q8NAP3
VPGYSEDGGALRGEV

WIPI1

396

Q5MNZ9
DTPYEPAEGGPRAEG

SHE

291

Q5VZ18
PYAEGPIQGGDAGEL

ZNF619

6

Q8N2I2
PYEGGGPVAGLDDSG

ZBTB22

386

O15209
GGKGEERYAEAGPAP

TEX13B

196

Q9BXU2
VKAEPPEADGGGGYG

KLF2

121

Q9Y5W3